MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202518050970 A) filed by Amgen Inc., Thousand Oaks, U.S.A., on May 27, for 'improved synthesis of kras g12c inhibitor compound.'
Inventor(s) include Parsons, Andrew T.; and Beaver, Matthew.
The application for the patent was published on June 27, under issue no. 26/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to an improved, efficient, scalable process to prepare intermediate compounds, such as 2,2',2''-(1,3,5,2,4,6-trioxatriborinane-2,4,6-triyl)tris(3- 5 fluorophenol), useful for the synthesis of compounds, such as Compound 9, for the treatment of KRAS G12C mutated cancers. Compound 9....